353 related articles for article (PubMed ID: 9018115)
1. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein.
Nielsen NH; Emdin SO; Cajander J; Landberg G
Oncogene; 1997 Jan; 14(3):295-304. PubMed ID: 9018115
[TBL] [Abstract][Full Text] [Related]
2. The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node.
Lodén M; Stighall M; Nielsen NH; Roos G; Emdin SO; Ostlund H; Landberg G
Oncogene; 2002 Jul; 21(30):4680-90. PubMed ID: 12096344
[TBL] [Abstract][Full Text] [Related]
3. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
Chatterjee SJ; George B; Goebell PJ; Alavi-Tafreshi M; Shi SR; Fung YK; Jones PA; Cordon-Cardo C; Datar RH; Cote RJ
J Pathol; 2004 Jul; 203(3):762-70. PubMed ID: 15221935
[TBL] [Abstract][Full Text] [Related]
4. Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation.
Lodén M; Nielsen NH; Roos G; Emdin SO; Landberg G
Oncogene; 1999 Apr; 18(16):2557-66. PubMed ID: 10353599
[TBL] [Abstract][Full Text] [Related]
5. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status.
Jares P; Rey MJ; Fernández PL; Campo E; Nadal A; Muñoz M; Mallofré C; Muntané J; Nayach I; Estapé J; Cardesa A
J Pathol; 1997 Jun; 182(2):160-6. PubMed ID: 9274525
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors.
Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A
Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity is associated with cell cycle deregulation in human breast cancer.
Landberg G; Nielsen NH; Nilsson P; Emdin SO; Cajander J; Roos G
Cancer Res; 1997 Feb; 57(3):549-54. PubMed ID: 9012489
[TBL] [Abstract][Full Text] [Related]
10. Determination of the prognostic value of cyclin D1 overexpression in breast cancer.
McIntosh GG; Anderson JJ; Milton I; Steward M; Parr AH; Thomas MD; Henry JA; Angus B; Lennard TW; Horne CH
Oncogene; 1995 Sep; 11(5):885-91. PubMed ID: 7675447
[TBL] [Abstract][Full Text] [Related]
11. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
Geradts J; Ingram CD
Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
Gillett CE; Smith P; Peters G; Lu X; Barnes DM
J Pathol; 1999 Jan; 187(2):200-6. PubMed ID: 10365095
[TBL] [Abstract][Full Text] [Related]
13. G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms.
Horton LE; Qian Y; Templeton DJ
Cell Growth Differ; 1995 Apr; 6(4):395-407. PubMed ID: 7794807
[TBL] [Abstract][Full Text] [Related]
14. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia.
Gillett CE; Lee AH; Millis RR; Barnes DM
J Pathol; 1998 Apr; 184(4):396-400. PubMed ID: 9664905
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E.
Sofer-Levi Y; Resnitzky D
Oncogene; 1996 Dec; 13(11):2431-7. PubMed ID: 8957085
[TBL] [Abstract][Full Text] [Related]
19. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
20. Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue.
Krecicki T; Smigiel R; Fraczek M; Kowalczyk M; Sasiadek MM
J Laryngol Otol; 2004 Sep; 118(9):676-80. PubMed ID: 15509364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
